Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

SHA:603392 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,215	5,493	11,167	5,702	2,337
Other Revenue	30.31	17.3	18.52	48.34	17.14
Revenue	2,245	5,511	11,185	5,750	2,354
Revenue Growth (YoY)	-59.25%	-50.73%	94.51%	144.25%	98.88%
Cost of Revenue	866.34	1,084	1,198	850.67	473.6
Gross Profit	1,379	4,427	9,987	4,900	1,881
Selling, General & Admin	790.16	1,878	3,490	1,874	810.21
Research & Development	874.57	1,177	1,091	677.42	309.13
Other Operating Expenses	14.67	31.57	51.28	26.71	12.51
Operating Expenses	1,694	3,063	4,723	2,662	1,156
Operating Income	-315.37	1,364	5,265	2,238	724.74
Interest Expense	-8.32	-6.86	-7.67	-5.69	-1.69
Interest & Investment Income	169.09	186.88	78.26	21	18.58
Currency Exchange Gain (Loss)	7.42	13.01	27.89	-8.75	-14.29
Other Non Operating Income (Expenses)	-5.77	-1.87	-1	0.05	-0.79
EBT Excluding Unusual Items	-152.95	1,555	5,362	2,244	726.55
Gain (Loss) on Sale of Investments	36.71	24.66	9.98	0.03	0.35
Gain (Loss) on Sale of Assets	7.39	-1.08	-2.74	-0.97	0.42
Asset Writedown	-	-259.15	-	-	-
Other Unusual Items	176.33	73.7	213.42	80.85	37.13
Pretax Income	67.48	1,393	5,583	2,324	764.45
Income Tax Expense	-41.61	146.89	719.39	244.93	82.64
Earnings From Continuing Operations	109.09	1,247	4,863	2,079	681.82
Minority Interest in Earnings	-2.86	1.18	-127.51	-57.75	-4.82
Net Income	106.24	1,248	4,736	2,021	677
Net Income to Common	106.24	1,248	4,736	2,021	677
Net Income Growth	-91.48%	-73.65%	134.28%	198.59%	224.13%
Shares Outstanding (Basic)	1,328	1,260	1,250	1,230	1,195
Shares Outstanding (Diluted)	1,328	1,260	1,250	1,230	1,195
Shares Change (YoY)	5.37%	0.86%	1.55%	2.96%	8.71%
EPS (Basic)	0.08	0.99	3.79	1.64	0.57
EPS (Diluted)	0.08	0.99	3.79	1.64	0.57
EPS Growth	-91.92%	-73.88%	130.69%	190.01%	198.16%
Free Cash Flow	-532.27	378.15	3,203	634.16	77.77
Free Cash Flow Per Share	-0.40	0.30	2.56	0.52	0.07
Dividend Per Share	-	0.320	0.714	0.099	0.088
Dividend Growth	-	-55.20%	624.44%	12.04%	-
Gross Margin	61.42%	80.34%	89.29%	85.21%	79.88%
Operating Margin	-14.04%	24.75%	47.07%	38.91%	30.78%
Profit Margin	4.73%	22.64%	42.34%	35.15%	28.76%
Free Cash Flow Margin	-23.71%	6.86%	28.63%	11.03%	3.30%
EBITDA	-65.06	1,579	5,401	2,334	809.21
EBITDA Margin	-2.90%	28.66%	48.28%	40.59%	34.37%
D&A For EBITDA	250.31	215.29	136.17	96.2	84.47
EBIT	-315.37	1,364	5,265	2,238	724.74
EBIT Margin	-14.04%	24.75%	47.07%	38.91%	30.78%
Effective Tax Rate	-	10.54%	12.89%	10.54%	10.81%
Revenue as Reported	2,245	5,511	11,185	5,750	2,354

Source: S&P Global Market Intelligence. Standard template. Financial Sources.